The in vitro component demonstrated that each glucagon and Retatrutide straight reduced ANGPTL3/8 secretion from hepatocytes, and this outcome was blocked by a glucagon receptor (GCGR) antagonist. These conclusions counsel which the GCGR agonism of Retatrutide contributes to your reduction in circulating ANGPTL3/eight, which consequently could brin